Episode 18: Karen Petrou and David Brint - BioBonds

Episode 18 March 23, 2022 00:55:46
Episode 18: Karen Petrou and David Brint - BioBonds
Few & Far Between: How Biotech Gets Built
Episode 18: Karen Petrou and David Brint - BioBonds

Mar 23 2022 | 00:55:46

/

Show Notes

On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.

Other Episodes

Episode 24

October 06, 2022 00:39:58
Episode Cover

Episode 24: Gadi Lachman, President and CEO, TriNetX

Can data sharing make the world a better place? Listen in to the latest episode of Few & Far Between. Biorasi CEO, Chris O'Brien,...

Listen

Episode 8

August 18, 2021 00:41:04
Episode Cover

Episode 8: David Rose, Rare Disease Speaker and Advocate

On today's podcast, speaker and rare disease advocate David Rose talks with Biorasi's Dr. Raul Silveira about occipital horn syndrome and supporting rare disease...

Listen

Episode 19

April 20, 2022 00:36:19
Episode Cover

Episode 19: Leslie Michelson, Founder and CEO, Private Health Management

How do you obtain the best possible patient care available? On this week's Few & Far Between podcast, host Chris O'Brien welcomes patient advocacy...

Listen